Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey Nikolaev

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Urology|August 30, 2014
Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris)Stanislav Kocherov, Ibrahim Ulman, Sergey Nikolaev, et al.
Nucleic Acids Research|September 21, 2022
A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strandAlina G Mikhailova, Alina A Mikhailova, Kristina Ushakova, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
Nature|April 29, 2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1Lambros Tselikas, Sandrine Susini, Matthieu Texier, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
ESR1 mutation in Endocrine treatment naive Endometrial Cancer: Prevalence, Characteristics and Prognostic Implications, results from the UTOLA phase II GINECO trialFélix Blanc-Durand, Catherine Genestie, Sergey Nikolaev, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Recurrent resistance mutations to lirafugratinib inform treatment sequencing in FGFR2-driven tumorsFrancesco Facchinetti, Antoine Hollebecque, Rémy Barbé, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 18, 2019
An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndromeManon Suerink, Mar Rodríguez-Girondo, Heleen M van der Klift, et al.
Genome Research|June 15, 2007
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genomeElliott H Margulies, Gregory M Cooper, George Asimenos, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Urology|August 30, 2014
Multicenter survey of endoscopic treatment of vesicoureteral reflux using polyacrylate-polyalcohol bulking copolymer (Vantris)Stanislav Kocherov, Ibrahim Ulman, Sergey Nikolaev, et al.
Nucleic Acids Research|September 21, 2022
A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strandAlina G Mikhailova, Alina A Mikhailova, Kristina Ushakova, et al.
Blood|October 26, 2021
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformationXiaona You, Fabao Liu, Moritz Binder, et al.
Nature|April 29, 2026
Safety and efficacy of intratumoural anti-CTLA4 with intravenous anti-PD1Lambros Tselikas, Sandrine Susini, Matthieu Texier, et al.
JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
ESR1 mutation in Endocrine treatment naive Endometrial Cancer: Prevalence, Characteristics and Prognostic Implications, results from the UTOLA phase II GINECO trialFélix Blanc-Durand, Catherine Genestie, Sergey Nikolaev, et al.
Nature Communications|May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axisRyan M Carr, Denis Vorobyev, Terra Lasho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Recurrent resistance mutations to lirafugratinib inform treatment sequencing in FGFR2-driven tumorsFrancesco Facchinetti, Antoine Hollebecque, Rémy Barbé, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 18, 2019
An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndromeManon Suerink, Mar Rodríguez-Girondo, Heleen M van der Klift, et al.
Genome Research|June 15, 2007
Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genomeElliott H Margulies, Gregory M Cooper, George Asimenos, et al.
Pageof 6